Experts in AI-powered lung image analysis


We combine medical science and deep learning technology to enable advanced treatment development in clinical trials and to support pulmonary clinical care across the globe.

15Mio+ images analyzed


600+ clinical installations


40+ countries worldwide


200+ scientific papers


Our customers and innovation partners


Our Expertise

High-precision quantitative analysis of thoracic CT scans for clinical applications


Quantification of anatomical volumes, parenchymal disease distributions, airway morphology, vascular morphology, and fissure completeness.

Pharmaceutical drug
and treatment development

Comprehensive clinical trial services, from study design and inclusion criteria to translation to clinical practice.

Specialized med-tech solutions for interventional medicine

Cooperation in designing clinical trials to optimize patient selection and treatment planning through imaging.

Powerful insights for personalized clinical care

Solutions for reliable and fast diagnosis, quantification of pulmonary pathologies and monitoring of chronic lung diseases.

Knowledge, quality and service with proven technology


Ready to apply AI image analysis to get better outcomes faster?

Let us help you find the perfect solution!


Talk to one of our experts to learn more.

Research & Innovation Projects


COPDGene: Genetic factors of chronic obstructive pulmonary disease

VR visualization of lungs for pre-operative planning of segmentectomy

Collaborative efforts to understand and deal with COVID-19

Papers & Publications


  • Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study | Nov 2023 | Respiratory Research

  • Automatic Analysis of Bronchus-Artery Dimensions to Diagnose and Monitor Airways Disease in Cystic Fibrosis | Sep 2023 | Thorax

  • Children with severe asthma have substantial structural airway changes on computed tomography | Aug 2023 | ERJ Open Research

  • The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting | Aug 2023 | Respiratory Research

  • Automatic Bronchus and Artery Analysis on Chest Computed Tomography to Evaluate the Effect of Inhaled Hypertonic Saline in Children Aged 3-6 Years With Cystic Fibrosis in a Randomized Clinical Trial | May 2023 | Journal of Cystic Fibrosis